documents: FDA-2006-D-0356-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2006-D-0356-0004 | FDA | FDA-2006-D-0356 | Draft Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Availability; Reopening of Comment Period | Notice | NEC-Notice of Extension | 2008-09-11T04:00:00Z | 2008 | 9 | 2008-09-11T04:00:00Z | 2008-10-15T03:59:59Z | 2024-11-12T04:19:51Z | E8-21197 | 1 | 0 | 09000064806ff38c |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref